Engineers Gate Manager LP Harrow Health, Inc. Transaction History
Engineers Gate Manager LP
- $5.55 Billion
- Q1 2025
A detailed history of Engineers Gate Manager LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 12,070 shares of HROW stock, worth $449,486. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,070
Previous 7,024
71.84%
Holding current value
$449,486
Previous $235,000
36.6%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HROW
# of Institutions
178Shares Held
21.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$147 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$80 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$70.4 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$69.5 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$35.6 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.01B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...